Predicting individual outcomes after radical cystectomy: An external validation of current nomograms

BJU International

Volumn 106, Issue 3, 2010, Pages 342-348

  Zaak, Dirk ^a,b   Burger, Maximilian ^c   Otto, Wolfgang ^c   Bastian, Patrick J ^a   Denzinger, Stefan ^c   Stief, Christian G ^a   Buchner, Hannes ^d   Hartmann, Arndt ^e   Wieland, Wolf F ^c   Shariat, Shahrokh F ^f   Fritsche, Hans Martin ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Clinic Traunstein   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bladder cancer; Evaluation; Nomogram; Prognosis; Radical cystectomy; Urothelial carcinoma

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CYSTECTOMY; EUROPE; EXTERNAL VALIDITY; FEMALE; HUMAN; INTERNAL VALIDITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; CYSTECTOMY; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS; PROGNOSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 77955747027     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.09138.x     Document Type: Article

References (26)

1. Touijer K, Scardino PT. Nomograms for staging, prognosis, and predicting treatment outcomes. Cancer 2009 115 (Suppl. 3107 3111
2. Sylvester RJ, van der Meijden AP, Oosterlinck W et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006 49 : 466 465
3. Margulis V, Lotan Y, Montorsi F, Shariat SF. Predicting survival after radical cystectomy for bladder cancer. BJU Int 2008 102 : 15 22
4. El-Mekresh M, Akl A, Mosbah A, Abdel-Latif M, Abol-Enein H, Ghoneim MA. Prediction of survival after radical cystectomy for invasive bladder carcinoma: risk group stratification, nomograms or artificial neural networks? J Urol 2009 182 : 466 472
5. International Bladder Cancer Nomogram Consortium. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol 2006 24 : 3967 72
6. Shariat SF, Karakiewicz PI, Palapatuu GS et al. Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin Cancer Res 2006 12 : 6663 6676
7. Karakiewicz PI, Shariat SF, Palapattu GS et al. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. J Urol 2006 176 : 1354 1362
8. BCRC. Nomogram. Available at: http://www.nomogram.org. Accessed 5 December 2009
9. IBCN Nomogram. Available at: http://www.nomograms.org. Accessed 5 December 2009
10. Steyerberg EW, Bleeker SE, Moll HA, Grobbee DE, Moons KG. Internal and external validation of predictive models: a simulation study of bias and precision in small samples. J Clin Epidemiol 2003 56 : 441 447
11. Graefen M, Karakiewicz PI, Cagiannos I et al. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2002 20 : 3206 3212 (Pubitemid 34831516)
12. Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med 1999 130 : 515 524
13. Epstein JI, Amin MB, Reuter VR et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998 22 : 1435 1448
14. Greene FL, Page DL, Fleming ID et al. AJCC Cancer Staging Manual, 6th edn. New York : Springer, 2002
15. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr 1974 AC 19 : 716 723
16. R-project. Open-source-software. Available at: http://www.rproject.org. Accessed 5 December 2009
17. Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 2001 93 : 358 366
18. Shariat SF, Margulis V, Lotan Y, Montorsi F, Karakiewicz PI. Nomograms for bladder cancer. Eur Urol 2008 54 : 41 53
19. Lopez-Beltran A, Sauter G, Knowles MA et al. Tumours of the Urinary System Eble JN, Sauter G, Epstein JI, Sesterhenn IA, World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon : IARC Press, 2004 : 93 109
20. Shariat SF, Karakiewicz PI, Ashfaq R et al. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy. Cancer 2008 112 : 315 325
21. Volkmer BG, Kuefer R, Bartsch G et al. Effect of a pT0 cystectomy specimen without neoadjuvant therapy on survival. Cancer 2005 104 : 2384 2391
22. Shariat SF, Palapattu GS, Karakiewicz PI et al. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy. Eur Urol 2007 51 : 152 160
23. Witjes JA, Moonen PM, van der Heijden AG. Review pathology in a diagnostic bladder cancer trial: effect of patient risk category. Urology 2006 67 : 751 755
24. Kattan MW. Should I use this nomogram? BJU Int 2008 102 : 421 422
25. Kattan M. Editorial: validating a prognostic model. Cancer 2006 107 2524
26. Catto JWF. More nomograms or better evidence of efficacy. What do we need in urologic oncology? Eur Urol 2008 54 : 11 2